Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 28 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/1/1998


1.		Phase III Randomized Study of Irinotecan vs Irinotecan/Fluorouracil/Leucovorin vs Fluorouracil/Leucovorin for Untreated Metastatic Colorectal Cancer (Summary Last Modified 12/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-95051 P-UPJOHN-MSKCC-95051, NCI-V96-0913

Last Modified: 5/17/2007 First Published: 5/1/1998


2.		Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Pharmaceutical / Industry				FRE-GERCOR-C97-3/CPTF308 FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260

Last Modified: 9/10/2008 First Published: 5/1/1999


3.		Phase III Randomized Study of Fluorouracil and Leucovorin Calcium With or Without Irinotecan Following Curative Resection in Patients With Stage III Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				CLB-89803 CAN-NCIC-CO15, E-89803, NCCTG-C89803, SWOG-C89803, NCT00003835, C89803, CO15

Last Modified: 6/1/2007 First Published: 3/1/2000


4.		Phase III Randomized Study of High-Dose Fluorouracil and Leucovorin Calcium With or Without Irinotecan in Patients With Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 02/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								EORTC-40986 NCT00004885

Last Modified: 6/12/2007 First Published: 7/1/2000


5.		Phase III Randomized Study of Adjuvant Leucovorin Calcium and Fluorouracil With or Without Irinotecan in Patients With Resected Stage III Colon Cancer at High Risk of Recurrence

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Other				FRE-FNCLCC-ACCORD-2 FFCD-9802, EU-20014, NCT00005979

Last Modified: 2/8/2007 First Published: 8/1/2000


6.		Phase III Study of Fluorouracil, Leucovorin Calcium, and Irinotecan in Patients With Metastatic, Locally Advanced, or Recurrent Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Not specified				NCI				CLB-9864 E-C9864, NCT00006103, C9864

Last Modified: 7/17/2007 First Published: 1/1/2001


7.		Phase III Randomized Study of Fluorouracil With Leucovorin Calcium and Either Irinotecan or Oxaliplatin in Patients With Unresectable Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				MRC-CR08-FOCUS EU-20038, ISRCTN79877428, NCT00008060

Last Modified: 1/16/2008 First Published: 3/1/2001


8.		Phase III Randomized Study of Bevacizumab (rhuMAb VEGF) With Fluorouracil and Leucovorin Calcium With or Without Irinotecan in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				GENENTECH-AVF2107g UCLA-0008022, NCT00012233

Last Modified: 3/29/2004 First Published: 4/1/2001


9.		Phase III Randomized Study of Regional and Systemic Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Patients With Unresectable Colorectal Cancer Metastatic to the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCI-01-C-0093 NCT00020501

Last Modified: 9/1/2001 First Published: 7/1/2001


10.		Phase III Randomized Study of Fluorouracil, Leucovorin Calcium, and Irinotecan With or Without SU5416 in Patients With Previously Untreated Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-001003701 SUGEN-SU5416.035, NCI-G01-1980, NCT00021281

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute